Physician profile
Anuj Behal
NPI 1699053637
$1,048.76
in general payments reported to CMS, 2019-2025
10 companies · $158 in 2025
The $158 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.88 · 2020: $24.99 · 2022: $54.21 · 2024: $797 · 2025: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $641 · Travel and Lodging: $315.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $640.95 |
| Travel and Lodging | $314.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon INC. | $460.04 | 2024 | Monarch Platform |
| Medical Device Business Services, INC. | $314.73 | 2024 | Monarch |
| Electromed, INC. | $54.21 | 2022 | |
| Amgen INC. | $43.10 | 2024-2025 | Tezspire |
| Lilly USA, LLC | $41.06 | 2025 | Zepbound, Mounjaro |
| Astrazeneca Pharmaceuticals Lp | $39.91 | 2025 | Breztri, Tezspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.18 | 2025 | Jascayd |
| Insmed, INC. | $25.66 | 2025 | Arikayce |
| Philips North America LLC | $24.99 | 2020 | |
| Glaxosmithkline, LLC. | $13.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anuj Behal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.